1. Home
  2. GOLF vs IOVA Comparison

GOLF vs IOVA Comparison

Compare GOLF & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOLF
  • IOVA
  • Stock Information
  • Founded
  • GOLF 1910
  • IOVA 2007
  • Country
  • GOLF United States
  • IOVA United States
  • Employees
  • GOLF N/A
  • IOVA N/A
  • Industry
  • GOLF Recreational Games/Products/Toys
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GOLF Consumer Discretionary
  • IOVA Health Care
  • Exchange
  • GOLF Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • GOLF 4.1B
  • IOVA 3.6B
  • IPO Year
  • GOLF 2016
  • IOVA N/A
  • Fundamental
  • Price
  • GOLF $65.41
  • IOVA $10.01
  • Analyst Decision
  • GOLF Buy
  • IOVA Strong Buy
  • Analyst Count
  • GOLF 7
  • IOVA 10
  • Target Price
  • GOLF $66.43
  • IOVA $24.80
  • AVG Volume (30 Days)
  • GOLF 325.7K
  • IOVA 6.9M
  • Earning Date
  • GOLF 10-31-2024
  • IOVA 11-05-2024
  • Dividend Yield
  • GOLF 1.31%
  • IOVA N/A
  • EPS Growth
  • GOLF N/A
  • IOVA N/A
  • EPS
  • GOLF 2.90
  • IOVA N/A
  • Revenue
  • GOLF $2,397,763,000.00
  • IOVA $32,772,000.00
  • Revenue This Year
  • GOLF $5.33
  • IOVA $13,836.92
  • Revenue Next Year
  • GOLF $3.83
  • IOVA $183.20
  • P/E Ratio
  • GOLF $23.04
  • IOVA N/A
  • Revenue Growth
  • GOLF 0.69
  • IOVA 13669.75
  • 52 Week Low
  • GOLF $49.42
  • IOVA $3.21
  • 52 Week High
  • GOLF $74.77
  • IOVA $18.33
  • Technical
  • Relative Strength Index (RSI)
  • GOLF 43.52
  • IOVA 46.05
  • Support Level
  • GOLF $66.02
  • IOVA $10.32
  • Resistance Level
  • GOLF $68.16
  • IOVA $11.80
  • Average True Range (ATR)
  • GOLF 1.58
  • IOVA 0.60
  • MACD
  • GOLF -0.10
  • IOVA -0.22
  • Stochastic Oscillator
  • GOLF 1.40
  • IOVA 11.86

About GOLF Acushnet Holdings Corp.

Acushnet Holdings Corp is engaged in the design, development, manufacture, and distribution of golf products. Its product category includes golf balls, golf shoes, golf clubs, wedges, putters, golf gloves, golf gear and golf wear, of which key revenue is derived from the sales of golf balls and golf gloves. The operating segments of the company are Titleist golf balls, Titleist golf clubs, Titleist golf gear and FootJoy golf wear. Geographically, the company operates in the United States, EMEA, Japan, Korea and other countries, of which a majority of the revenue is generated from the operations in the United States.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: